method for treating or preventing demyelination in a subject in need thereof; pharmaceutical composition; method for preventing progress of a demyelinating disease in a patient; method for treating progressive multiple sclerosis in a patient; and method of preventing or reducing the severity of the initiation phase of the autoimmune response in a patient who has a demyelinating disease.

摘要

abstract method for treating or preventing demyelination in a subject in need thereof; pharmaceutical composition; method for preventing progress of a demyelinating disease in a patient; method for treating progressive multiple sclerosis in a patient; and Method for Preventing or Reducing the Severity of the Autoimmune Response Initiation Phase in a Patient Having a Demyelinating Disease New oral pharmaceutical compositions of SAMC inhibitors, polyamine analogs and polyamine biosynthesis inhibitors, and their applications are disclosed herein. for treatment of conditions including demyelinating diseases, autoimmune diseases affecting the nervous system and other neurodegenerative conditions. 1/1